Meeting
2023 ASCO Genitourinary Cancers Symposium
EphA2 on urinary extracellular vesicles as a novel diagnostic marker for bladder cancer and its effect on the invasiveness of bladder cancer.
Authors
Eisuke Tomiyama
Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Eisuke Tomiyama , Kazutoshi Fujita , Taigo Kato , Koji Hatano , Atsunari Kawashima , Norio Nonomura
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 539)
DOI
10.1200/JCO.2023.41.6_suppl.539
Abstract #
539
Poster Bd #
M2
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
A multi-analyte assay for the noninvasive detection of bladder cancer.
First Author: Makito Miyake
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2023 ASCO Genitourinary Cancers Symposium
Survey of keratin 17 (K17) expression in different urothelial malignancies.
First Author: Thorsten Ecke
Poster
2018 Genitourinary Cancers Symposium
Transcriptome-wide analysis of alternative splicing events in bladder cancer: Novel biomarkers discovery for early diagnosis.
First Author: Claudio Jeldres